advertisement

11.5 Carbonic anhydrase inhibitors (40)

Showing records 1 to 25

Display only abstracts from IGR 9-2 in classification 11.5 Carbonic anhydrase inhibitors

90819 Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
Mishra CB; Tiwari M; Supuran CT
Medicinal Research Reviews 2020; 40: 2485-2565 (IGR: 21-3)

79567 The effect on wound healing of pazopanib and bevacizumab compared with corticosteroid in experimental glaucoma filtration surgery
Kobat SG; Celiker FU; Dagli AF; Kasar K
International Journal of Ophthalmology 2018; 11: 1909-1915 (IGR: 20-2)

79293 Brinzolamide-induced Follicular Conjunctivitis
Young JW; Clements JL; Morrison JC; Takusagawa HL
Journal of Glaucoma 2018; 27: e183-e184 (IGR: 20-1)

61749 HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese
Yang F; Xuan J; Chen J; Zhong H; Luo H; Zhou P; Sun X; He L; Chen S; Cao Z; Luo X; Xing Q
Pharmacogenomics Journal 2016; 16: 83-87 (IGR: 17-1)

60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Bae HW; Kim JH; Kim S; Kim M; Lee N; Hong S; Seong GJ; Kim CY
Journal of ginseng research 2015; 39: 7-13 (IGR: 16-4)

56950 Carbonic anhydrase inhibitors in corneal endothelial transport
Malikowski TM; Bosch JB; Min S; Duffey ME; Patel SP
Investigative Ophthalmology and Visual Science 2014; 55: 2652-2658 (IGR: 16-2)

50296 Oral Acetazolamide after Boston Keratoprosthesis in Stevens Johnson Syndrome
Kumar R; Dohlman CH; Chodosh J
BMC research notes 2012; 5: 205 (IGR: 14-2)

48967 Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo
Carta F; Aggarwal M; Maresca A; Scozzafava A; McKenna R; Masini E; Supuran CT
Journal of Medicinal Chemistry 2012; 55: 1721-1730 (IGR: 14-1)

48948 Topical drug delivery to the eye: dorzolamide
Loftsson T; Jansook P; Stefá,nsson E
Acta Ophthalmologica 2012; 90: 603-608 (IGR: 14-1)

46475 Vision loss and recovery after trabeculectomy: Risk and associated risk factors
Francis BA; Hong B; Winarko J; Kawji S; Dustin L; Chopra V
Archives of Ophthalmology 2011; 129: 1011-1017 (IGR: 13-3)

22691 The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition
Torring MS; Holmgaard K; Hessellund A; Aalkjaer C; Bek T
Investigative Ophthalmology and Visual Science 2009; 50: 345-351 (IGR: 11-1)

21497 The mechanisms by which latanoprost free acid inhibits human carbonic anhydrase I and II
Sugimoto A; Ikeda H; Tsukamoto H; Kihira K; Takeda C; Hirose J; Hata T; Baba E; Ono Y
Biological & Pharmaceutical Bulletin 2008; 31: 796-801 (IGR: 10-3)

21191 Carbonic anhydrases - An overview
Supuran CT
Current Pharmaceutical Design 2008; 14: 603-614 (IGR: 10-2)

21189 Diuretics: From classical carbonic anhydrase inhibitors to novel applications of the sulfonamides
Supuran CT
Current Pharmaceutical Design 2008; 14: 641-648 (IGR: 10-2)

21285 Effect of antiglaucoma agents on postoperative intraocular pressure after phacoemulsification with viscoelastics
Xie X-H; Mao A-Z
International Journal of Ophthalmology 2008; 8: 516-518 (IGR: 10-2)

20694 Purification of carbonic anhydrase from dog erythrocytes and investigation of in vitro inhibition by various compounds
Bayram T; Arslan O; Ugras HI; Cakir U; Ozensoy O
Journal of Enzyme Inhibition and Medicinal Chemistry 2007; 22: 739-744 (IGR: 10-1)

20590 Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: Kinetic and X-ray crystallographic studies
Guzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorganic and Medicinal Chemistry Letters 2008; 18: 152-158 (IGR: 10-1)

20693 Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators
Supuran CT
Nature Reviews Drug Discovery 2008; 7: 168-181 (IGR: 10-1)

20089 Variable involvement of the perivascular retinal tissue in carbonic anhydrase inhibitor induced relaxation of porcine retinal arterioles in vitro
Kehler AK; Holmgaard K; Hessellund A; Aalkjaer C; Bek T
Investigative Ophthalmology and Visual Science 2007; 48: 4688-4693 (IGR: 9-4)

19414 Quantitative structure activity relationship studies of sulfamide derivatives as carbonic Anhydrase inhibitor: As antiglaucoma agents
Kumar S; Singh V; Tiwari M
Medicinal Chemistry 2007; 3: 379-386 (IGR: 9-3)

19394 Therapeutic applications of the carbonic anhydrase inhibitors
Supuran CT
Therapy 2007; 4: 355-378 (IGR: 9-3)

19411 Metal binding functions in the design of carbonic anhydrase inhibitors
Winum J-Y; Scozzafava A; Montero J-L; Supuran CT
Current Topics in Medicinal Chemistry 2007; 7: 835-848 (IGR: 9-3)

17455 Analysis of human carbonic anhydrase II: Docking reliability and receptor-based 3D-QSAR study
Tuccinardi T; Nuti E; Ortore G; Supuran CT; Rossello A; Martinelli A
Journal of Chemical Information and Modeling 2007; 47: 515-525 (IGR: 9-2)

17135 A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors
Clare BW; Supuran CT
Expert Opinion on Drug Metabolism and Toxicology 2006; 2: 113-137 (IGR: 9-1)

17091 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors
Weber A; Bohm M; Supuran CT; Scozzafava A; Sotriffer CA; Klebe G
Journal of Chemical Information and Modeling 2006; 46: 2737-2760 (IGR: 9-1)

• «
• 1
• 2
• »